“NFBD1/KIAA0170 is a novel nuclear transcriptional transactivator with BRCT domain”.DNA Cell Biol19(8): 475–485.(Sep 2000).doi:10.1089/10445490050128403.PMID10975465.
“MDC1 regulates DNA-PK autophosphorylation in response to DNA damage”.J Biol Chem279(45): 46359–62.(Nov 2004).doi:10.1074/jbc.c400375200.PMID15377652.
“NFBD1/MDC1 associates with p53 and regulates its function at the crossroad between cell survival and death in response to DNA damage.”.J Biol Chem282(31): 22993–3004.(Aug 2007).doi:10.1074/jbc.m611412200.PMID17535811.
“MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals”.Mol Cell21(2): 187–200.(Jan 2006).doi:10.1016/j.molcel.2005.11.025.PMID16427009.
“The DNA damage response mediator MDC1 directly interacts with the anaphase-promoting complex/cyclosome”.J Biol Chem282(44): 32053–32064.(Sep 2007).doi:10.1074/jbc.m705890200.PMID17827148.
“MicroRNA-22 Suppresses DNA Repair and Promotes Genomic Instability through Targeting of MDC1”.Cancer Research75(7): 1298–1310.(Apr 2015).doi:10.1158/0008-5472.CAN-14-2783.PMID25627978.
“DNA damage response mediators MDC1 and 53BP1: constitu- tive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours”.Oncogene26(53): 7414–7422.(Jun 2007).doi:10.1038/sj.onc.1210553.PMID17546051.
“Growth inhibition, morphology change, and cell cycle alterations in NFBD1-depleted human esophageal cancer cells”.Mol Cell Biochem342(1–2): 1–6.(Sep 2010).doi:10.1007/s11010-010-0460-3.PMID20364298.
“NFBD1/MDC1 is a protein of oncogenic potential in human cervical cancer”.Mol Cell Biochem359(1–2): 333–46.(Jan 2010).doi:10.1007/s11010-011-1027-7.PMID21853275.
“NFBD1/KIAA0170 is a novel nuclear transcriptional transactivator with BRCT domain”.DNA Cell Biol19(8): 475–485.(Sep 2000).doi:10.1089/10445490050128403.PMID10975465.
“MDC1 regulates DNA-PK autophosphorylation in response to DNA damage”.J Biol Chem279(45): 46359–62.(Nov 2004).doi:10.1074/jbc.c400375200.PMID15377652.
“NFBD1/MDC1 associates with p53 and regulates its function at the crossroad between cell survival and death in response to DNA damage.”.J Biol Chem282(31): 22993–3004.(Aug 2007).doi:10.1074/jbc.m611412200.PMID17535811.
“MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals”.Mol Cell21(2): 187–200.(Jan 2006).doi:10.1016/j.molcel.2005.11.025.PMID16427009.
“The DNA damage response mediator MDC1 directly interacts with the anaphase-promoting complex/cyclosome”.J Biol Chem282(44): 32053–32064.(Sep 2007).doi:10.1074/jbc.m705890200.PMID17827148.
“MicroRNA-22 Suppresses DNA Repair and Promotes Genomic Instability through Targeting of MDC1”.Cancer Research75(7): 1298–1310.(Apr 2015).doi:10.1158/0008-5472.CAN-14-2783.PMID25627978.
“DNA damage response mediators MDC1 and 53BP1: constitu- tive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours”.Oncogene26(53): 7414–7422.(Jun 2007).doi:10.1038/sj.onc.1210553.PMID17546051.
“Growth inhibition, morphology change, and cell cycle alterations in NFBD1-depleted human esophageal cancer cells”.Mol Cell Biochem342(1–2): 1–6.(Sep 2010).doi:10.1007/s11010-010-0460-3.PMID20364298.
“NFBD1/MDC1 is a protein of oncogenic potential in human cervical cancer”.Mol Cell Biochem359(1–2): 333–46.(Jan 2010).doi:10.1007/s11010-011-1027-7.PMID21853275.